Anavex Life Sciences Announces First Patient Dosed in Extension Study to its U.S. Phase 2 Clinical Trial of ANAVEX®2-73 in Patients for Rett Syndrome

June 25, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search